newsfilter
← Latest News
PR Newswire·

Ampio Pharmaceuticals' CEO Mike Martino Issues Letter to Stockholders

ENGLEWOOD, Colo., June 2, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE:AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for the treatment of pain resulting from osteoarthritis in the knee and potential